Does anakinra reduce recurrences, emergency department admissions, and hospitalisations in patients with corticosteroid-dependent and colchicine-resistant recurrent pericarditis?
Anakinra is an efficacious and safe treatment option for reducing recurrences and healthcare utilization in patients with refractory recurrent pericarditis.
In patients with recurrent pericarditis, anakinra appears efficacious and safe in reducing recurrences, emergency department admissions and hospitalisations.
Imazio et al. (2019) studied this question.